APA (7th ed.) Citation

DF, F., AD, H., V, R., D, W., A, B., EK, B., . . . S, G. (2017). Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer. Oncotarget, 9(3), 3321. https://doi.org/10.18632/oncotarget.22925

Chicago Style (17th ed.) Citation

DF, Fukushiro-Lopes, et al. "Preclinical Study of a Kv11.1 Potassium Channel Activator as Antineoplastic Approach for Breast Cancer." Oncotarget 9, no. 3 (2017): 3321. https://doi.org/10.18632/oncotarget.22925.

MLA (9th ed.) Citation

DF, Fukushiro-Lopes, et al. "Preclinical Study of a Kv11.1 Potassium Channel Activator as Antineoplastic Approach for Breast Cancer." Oncotarget, vol. 9, no. 3, 2017, p. 3321, https://doi.org/10.18632/oncotarget.22925.